Shmuel “Muli” Ben Zvi, Ph.D.

Shmuel “Muli” Ben Zvi, Ph.D.

DirectoratProtalix BioTherapeutics· In proxies 2023–2025

Shmuel “Muli” Ben Zvi, Ph.D. is Director of Protalix BioTherapeutics.

Experience

  1. Protalix BioTherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?